Health
Viral ‘molecular scissor’ is next COVID-19 drug target: Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins – Benzinga
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the …
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the infection, researchers at The University of Texas Health Science Center at San Antonio and the Wroclaw University of Science and Technology discovered.
SAN ANTONIO (PRWEB) October 18, 2020
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design blocking a molecular “scissor” tha…
-
Noosa News15 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Business22 hours agoprofit up 7%, guidance strong
-
Noosa News14 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Noosa News19 hours agoItalian Film Festival, Brisbane: All the Details